Palmitoylethanolamide (PEA) Induces an Increase in Spleen Regulatory T Cells, Reduces CD8+ Cells and TNF-α Levels in Target Organs, and Protects Mice from Graft-Versus-Host Disease-Related Mortality through PPAR Activation without Compromising the Graft-Versus-Tumor Response

By
Jamie Kang
-
0
50
Researchers found that palmitoylethanolamide created an immunoregulatory environment in the spleen by reducing the activation of CD3+CD4+ cells.
[Immunology]
Full Article